New research finds genetic differences in antibody genes alter susceptibility to rheumatic heart disease, a forgotten inflammatory heart condition – known as ‘RHD’ – that is rife in developing countries. Rheumatic heart disease is triggered by ...
Congratulations to Prof Yvonne Jones and Prof Hugh Watkins, elected FRS 2017. Professor Jones' research focuses on the structural biology of cell surface recognition and signalling complexes. Professor Watkins is interested in using molecular genetic analysis of cardiovascular disease as a tool to define disease mechanisms and therapeutic targets.
The many potential social and economic benefits from advances in AI-based technologies depend entirely on the environment in which these technologies evolve, says the Royal Society. According to a new report from the UK’s science academy, urgent ...
A big data study of hepatitis C and more than 500 patients with the virus has opened the way for a better understanding of how the virus interacts with its human hosts.
Researchers have for the first time shown that standard tuberculosis (TB) diagnostic tests can be replaced by a sub-24 hour genetic test applied to the TB bacteria in a patient’s sputum. Dr Zamin Iqbal from the Wellcome Trust Centre of Human Genetics co-led this study.
LAB282, the £13m drug discovery partnership for Oxford University, has made its first wave of awards, backing projects targeting cardiovascular and infectious diseases including the 'Drugs from Bugs' project led by Prof. Shoumo Bhattacharya.
Professor Cecilia Lindgren has received the Khwarizmi International Award (KIA) for her work on "Dissection of the Molecular Pathogenesis of Obesity and Fat distribution". The Khwarizmi International Award seeks to recognize the efforts made by researchers, innovators and inventors from all over the world.
Specially invited speakers, among them some of the world's finest researchers, will speak about their latest achievements and research on colorectal cancer. The lectures are open to all interested in advances within research on colorectal cancer, and the theme for this meeting is Genomic stability and instability in cancer.
WTCHG Director, Prof Peter Donnelly, spoke as part of a Prof Brian Cox chaired panel for the Royal Society's event "Science Matters - Machine Learning and Artificial intelligence".
Wellcome has announced funding of £118 million to 14 major research centres, including three centres based in Oxford. The Wellcome Centre for Human Genetics, based in Oxford for 22 years, has played a pioneering role in the progress and success of human disease genetics and mechanism research.